Safety, tolerability and treatment effectiveness of chronic hepatitis B patients with pradefovir: a phase 1b multiple ascending dose study

被引:0
|
作者
Jingrui, L. [1 ]
Junqi, N. [1 ]
Yanhua, D. [1 ]
Ning, X. [2 ]
Xiaoxue, Z. [1 ]
Xiaojiao, L. [1 ]
机构
[1] Jilin Univ, Hosp 1, Changchun, Peoples R China
[2] Jilin Univ, Hosp 4, Changchun, Peoples R China
关键词
D O I
10.1016/S0168-8278(17)30471-3
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
LBP-526
引用
收藏
页码:S105 / S105
页数:1
相关论文
共 50 条
  • [41] Entecavir safety and effectiveness in a national cohort of treatment-naive chronic hepatitis B patients in the US - the ENUMERATE study
    Ahn, J.
    Lee, H. M.
    Lim, J. K.
    Pan, C. Q.
    Nguyen, M. H.
    Kim, W. Ray
    Mannalithara, A.
    Trinh, H.
    Chu, D.
    Tran, T.
    Min, A.
    Do, S.
    Te, H.
    Reddy, K. R.
    Lok, A. S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (01) : 134 - 144
  • [42] Effectiveness of Tenofovir for the Treatment of chronic Hepatitis B
    不详
    GASTROENTEROLOGE, 2013, 8 (05): : 447 - 447
  • [43] Clinical Evaluation of MP4CO: A Phase 1b Escalating-Dose, Safety and Tolerability Study in Stable Adult Patients with Sickle Cell Disease
    Keipert, Peter E.
    Howard, Jo
    Thein, Swee Lay
    Galacteros, Frederic
    Inati, Adlette
    Reid, Marvin
    OXYGEN TRANSPORT TO TISSUE XXXVIII, 2016, 923 : 23 - 29
  • [44] Efficacy and safety of elbasvir/grazoprevir treatment for Chinese patients with hepatitis C virus genotype 1b: a retrospective study
    Li, Juan
    Li, Guangming
    Wang, Juanxia
    Zhao, Rui
    He, Jingjing
    Wang, Liang
    Zhang, Lingyi
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2022, 14 (06): : 3995 - +
  • [45] Comparative effectiveness and safety study of triple therapy with simeprevir or telaprevir for non-cirrhotic patients with chronic hepatitis C virus genotype 1b infection
    Ogawa, Eiichi
    Furusyo, Norihiro
    Kajiwara, Eiji
    Nomura, Hideyuki
    Kawano, Akira
    Takahashi, Kazuhiro
    Dohmen, Kazufumi
    Satoh, Takeaki
    Azuma, Koichi
    Nakamuta, Makoto
    Koyanagi, Toshimasa
    Kotoh, Kazuhiro
    Shimoda, Shinji
    Hayashi, Jun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 (12) : 1759 - 1767
  • [47] A dose-ranging study of the efficacy and tolerability of entecavir in lamivudine-refractory chronic hepatitis B patients
    Chang, TT
    Gish, RG
    Hadziyannis, SJ
    Cianciara, J
    Rizzetto, M
    Schiff, ER
    Pastore, G
    Bacon, BR
    Poynard, T
    Joshi, S
    Klesczewski, KS
    Thiry, A
    Rose, RE
    Colonno, RJ
    Hindes, RG
    GASTROENTEROLOGY, 2005, 129 (04) : 1198 - 1209
  • [48] Safety, pharmacokinetics and pharmacogenetics of a single ascending dose of pradefovir, a novel liver-targeting, anti-hepatitis B virus drug, in healthy Chinese subjects
    Yanhua Ding
    Hong Zhang
    Xiaojiao Li
    Cuiyun Li
    Guiling Chen
    Hong Chen
    Min Wu
    Junqi Niu
    Hepatology International, 2017, 11 : 390 - 400
  • [49] Results of a Phase 1b/2a Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of XmAb®5871 in Patients with Rheumatoid Arthritis (RA)
    Zack, Debra
    Baumann, Maria Jaraczewska
    Korkosz, Mariusz
    Suljok, Gabriella
    Sramek, Petr
    Rojkovich, Bernadette
    Daniluk, Stafan
    Bartalos, Janos
    Foster, Paul
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [50] Phase 1/1b Study of the Efficacy and Safety of the Combination of Panobinostat plus Carfilzomib in Patients with Relapsed and/or Refractory Multiple Myeloma
    Shah, Jatin J.
    Thomas, Sheeba K.
    Weber, Donna M.
    Wang, Michael
    Alexanian, Raymond
    Qazilbash, Muzaffar H.
    Bashir, Qaiser
    Parmar, Simrit
    Shah, Nina
    Popat, Uday R.
    Orlowski, Robert Z.
    BLOOD, 2012, 120 (21)